PRESS RELEASE published on 11/12/2025 at 07:30, 11 months 16 days ago Inside Information / Other news releases Adocia files patent for AdoXLongTM platform to extend duration of action for peptides in diabetes and obesity treatment. BioChaperone® platform updated with feasibility studies Obesity Treatment Diabetes Treatment Patent Filing ADOCIA AdoXLongTM
PRESS RELEASE published on 11/12/2025 at 07:30, 11 months 16 days ago Informations privilégiées / Autres communiqués ADOCIA dépose un brevet pour une nouvelle plateforme de peptides à action prolongée, AdoXLongTM, et fait avancer sa technologie BioChaperone® pour le traitement du diabète et de l'obésité Obésité Diabète ADOCIA Peptides Action Prolongée
BRIEF published on 10/21/2025 at 10:47, 1 year ago Crossing thresholds at ADOCIA Warrants Actions Crossing Thresholds ADOCIA Vester Finance
BRIEF published on 10/21/2025 at 10:47, 1 year ago Franchissement de seuils chez ADOCIA Actions Franchissement De Seuils Bons De Souscription ADOCIA Vester Finance
PRESS RELEASE published on 10/21/2025 at 10:42, 1 year ago Franchissement de seuils Déclaration de franchissement de seuils par Vester Finance pour ADOCIA avec 889 555 actions, 4,86% du capital et 4,36% des droits de vote Déclaration Actions Franchissement De Seuils ADOCIA Vester Finance
BRIEF published on 10/15/2025 at 08:50, 1 year ago Positive results for BioChaperone® Lispro insulin in Phase 3 Clinical Trial Type 1 Diabetes ADOCIA BioChaperone® Tonghua Dongbao
BRIEF published on 10/15/2025 at 08:50, 1 year ago Résultats positifs pour l'insuline BioChaperone® Lispro en Phase 3 Essai Clinique Diabète De Type 1 ADOCIA BioChaperone® Tonghua Dongbao
PRESS RELEASE published on 10/15/2025 at 08:45, 1 year ago Inside Information / Other news releases ADOCIA and Tonghua Dongbao announce positive Phase 3 results for Ultra-Rapid Insulin BioChaperone Lispro in Type 1 Diabetes treatment, showing non-inferior HbA1c reduction and improved blood glucose control post-meal Type 1 Diabetes Phase 3 Results ADOCIA Tonghua Dongbao Ultra-Rapid Insulin
PRESS RELEASE published on 10/15/2025 at 08:45, 1 year ago Informations privilégiées / Autres communiqués Adocia et Tonghua Dongbao annoncent des résultats positifs d'essai clinique de Phase 3 sur l'insuline BioChaperone® Lispro THDB0206 injection pour le Diabète de Type 1 en Chine Diabète De Type 1 ADOCIA Tonghua Dongbao Insuline BioChaperone Lispro
BRIEF published on 07/25/2025 at 08:50, 1 year 3 months ago Adocia et Tonghua Dongbao annoncent le succès de la phase 3 de leur projet d'insuline ultra-rapide Essai Clinique Traitement Du Diabète ADOCIA Résultats De La Phase 3 BioChaperone® Lispro
Published on 10/28/2026 at 08:00, 1 hour 12 minutes ago Algo Grande Copper Makes New Skarn Discovery at Adelita; Step-Out Hole AG-CG-PH2-003 Returns a Combined 139.81 Metres of 1.3% CuEq from Cerro Grande and the New Margarita Skarn
Published on 10/28/2026 at 02:55, 6 hours 17 minutes ago Challenger Underground MRE Doubles to 230koz @ 3.65 g/t Au
Published on 10/28/2026 at 02:50, 6 hours 22 minutes ago Letter to Shareholders Regarding Annual General Meeting
Published on 10/27/2026 at 23:40, 9 hours 32 minutes ago Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 9 hours 47 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/28/2026 at 09:05, 7 minutes ago Rivermate recognized as a key provider of EoR solutions in Everest Group's Employer of Record (EoR) Solutions PEAK Matrix® Assessment 2026
Published on 10/28/2026 at 09:00, 12 minutes ago Municipality Finance issues a GBP 30 million tap under its MTN programme
Published on 10/28/2026 at 09:00, 12 minutes ago PFISTERER Kontaktsysteme GmbH improves its sustainability rating and ranks among the top 3 percent of its industry
Published on 10/28/2026 at 08:00, 1 hour 12 minutes ago Edenred successfully raises €800 million in a dual-tranche bond offering
Published on 10/28/2026 at 08:00, 1 hour 12 minutes ago Edenred lève avec succès 800 millions d’euros dans le cadre d’une émission obligataire à deux tranches
Published on 10/27/2026 at 18:00, 15 hours 12 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 15 hours 12 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
